Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Eli Lilly & Co. for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Eli Lilly & Co. (NYSE:LLY)


Cash Flow Statement

Beginner level

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Eli Lilly & Co., consolidated cash flow statement

US$ in thousands

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net income (loss)
Gain related to disposition of Elanco
Gain on sale of antibiotic business in China
Depreciation and amortization
Change in deferred income taxes
Stock-based compensation expense
Acquired in-process research and development
Other non-cash operating activities, net
Receivables, (increase) decrease
Inventories, (increase) decrease
Other assets, (increase) decrease
Income taxes payable, increase (decrease)
Accounts payable and other liabilities, increase (decrease)
Other changes in operating assets and liabilities, net of acquisitions and divestitures
Adjustments to reconcile net income (loss) to cash flows from operating activities
Net cash provided by operating activities
Purchases of property and equipment
Cash (restricted) released for pending acquisition
Proceeds from sales and maturities of short-term investments
Purchases of short-term investments
Proceeds from sales of noncurrent investments
Purchases of noncurrent investments
Proceeds from sale of product rights
Purchases of in-process research and development
Cash paid for acquisitions, net of cash acquired
Cash distributed to Elanco upon disposition
Cash received for sale of antibiotic business in China
Other investing activities, net
Net cash (used for) provided by investing activities
Dividends paid
Net change in short-term borrowings
Proceeds from issuance of long-term debt
Repayments of long-term debt
Purchases of common stock
Net proceeds from Elanco initial public offering
Other financing activities, net
Net cash provided by (used for) financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year

Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Eli Lilly & Co.’s net cash provided by operating activities decreased from 2017 to 2018 and from 2018 to 2019.
Net cash (used for) provided by investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Eli Lilly & Co.’s net cash (used for) provided by investing activities increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.
Net cash provided by (used for) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Eli Lilly & Co.’s net cash provided by (used for) financing activities decreased from 2017 to 2018 but then increased from 2018 to 2019 not reaching 2017 level.